申请人:Abbott Laboratories
公开号:US04988703A1
公开(公告)日:1991-01-29
An antiviral compound of the formula: ##STR1## wherein A is selected from a purin-9-yl group, a heterocyclic isostere of a purin-9-yl group, a pyrimidin-1-yl group and a heterocyclic isostere of a pyrimidin-1-yl group; and G and D are independently selected from hydrogen, C.sub.1 to C.sub.10 alkyl and substituted derivatives thereof, --OH, --C(O)H, --CO.sub.2 R.sub.1 l wherein R.sub.1 is hydrogen or C.sub.1 to C.sub.10 alkyl and --OCH.sub.2 PO.sub.3 H.sub.2, with the proviso that one of D or G is other than hydrogen or C.sub.1 to C.sub.10 alkyl; or a pharmaceutically acceptable salt thereof.
一种抗病毒化合物的化学结构如下:##STR1## 其中A从嘌呤-9-基团、嘌呤-9-基团的杂环同分异构体、嘧啶-1-基团和嘧啶-1-基团的杂环同分异构体中选择;G和D分别从氢、C.sub.1到C.sub.10烷基及其取代衍生物、--OH、--C(O)H、--CO.sub.2R.sub.1,其中R.sub.1为氢或C.sub.1到C.sub.10烷基,以及--OCH.sub.2PO.sub.3H.sub.2中选择,但其中D或G之一不是氢或C.sub.1到C.sub.10烷基;或其药用可接受盐。